Global /China /Healthcare /Drug Manufacturers - General /2289

Charmacy Pharmaceutical Co., Ltd.

2289

• SHEK: 2289 • Delayed

5.82HKD 0.2%

0.7427 USD

As of 14 June 2026, Charmacy Pharmaceutical Co., Ltd. has a market cap of $80.2M USD, ranking #27116 globally and #5970 in China. It ranks #2431 in the Healthcare sector, and #877 in the Drug Manufacturers - General industry.

Global Rank

27116

Country Rank

5970

Sector Rank

2431

Industry Rank

877

Key Stats

Market Cap

$80.2MUSD

628.56M HKD

Enterprise Value

$142.86MUSD

1.12B HKD

Revenue (TTM)

$622.57MUSD

4.88B HKD

EBITDA (TTM)

$21.82MUSD

170.94M HKD

Net Income (TTM)

$6.57MUSD

51.49M HKD

EBITDA Margin

3.5%

Profit Margin

1.1%

PE Ratio

12.2

PS Ratio

0.1

PB Ratio

0.9

EV/EBITDA

6.5

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Chuanglong Yao open_in_new

Employees

849

Founded

1984

Website

chmyy.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.2%	4.2%	0.2%	-20%	7.2%	-20%	-25%	-26%	18%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	2289 创美药业股份有限公司 Shs -H- Reg S ISIN: CNE1000023D6 Shares Out.: Shares Outstanding: 108.0M¹ Shares Float: 61.53M² TV: TradingView: HKEX: 2289 SA: Stock Analysis: HKG: 2289 YF: Yahoo Finance: 2289.HK GF: Google Finance: HKG: 2289 BA: Barron's: 2289 MS: Morningstar: XHKG: 02289	5.82 HKD	TV: TradingView: HKEX: 2289 SA: Stock Analysis: HKG: 2289 YF: Yahoo Finance: 2289.HK GF: Google Finance: HKG: 2289 BA: Barron's: 2289 MS: Morningstar: XHKG: 02289

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Charmacy Pharmaceutical Co., Ltd.

Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business in the People’s Republic of China. The company distributes western medicines, Chinese patent medicines, healthcare products, and pharmaceutical products to downstream distributors and retail terminals. It also offers pharmaceutical product related consulting services; and operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online, make inquires and payments, etc. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is based in Shantou, the People’s Republic of China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 67K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 62K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 35K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 23K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 20K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 20K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 950K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 682K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 450K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 401K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 360K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 342K%	20.5	Switzerland

chevron_leftBack